Leap Therapeutics
LPTX
LPTX
44 hedge funds and large institutions have $22.5M invested in Leap Therapeutics in 2024 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 11 increasing their positions, 10 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
2% more funds holding
Funds holding: 43 → 44 (+1)
21% less capital invested
Capital invested by funds: $28.5M → $22.5M (-$5.93M)
Holders
44
Holding in Top 10
–
Calls
$29K
Puts
$24K
Top Buyers
| 1 | +$1.78M | |
| 2 | +$1.22M | |
| 3 | +$1M | |
| 4 |
BC
BIT Capital
Berlin,
Germany
|
+$608K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$583K |
Top Sellers
| 1 | -$1.23M | |
| 2 | -$495K | |
| 3 | -$261K | |
| 4 |
PA
Perceptive Advisors
New York
|
-$186K |
| 5 |
BlackRock
New York
|
-$175K |